+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Stimuli-Responsive Nanocarriers. Recent Advances in Tailor-Made Therapeutics

  • Book

  • January 2022
  • Elsevier Science and Technology
  • ID: 5390293

Stimuli-Responsive Nanocarriers: Recent Advances in Tailor-Made Therapeutics compiles dispersed knowledge into a complete and comprehensive source to help researchers understand and progress stimuli-responsive nanocarriers. The book contains recent advancements made in the field of stimuli-responsive nanocarriers with their application in controlled drug delivery against various diseases. It focuses on the design, mechanism, construction, therapeutic application and future challenges of stimuli-responsive nanocarriers which will help new researchers in designing next generation tailor-made advanced therapeutics.� Finally, the book covers future aspects and challenges present in the route of development of stimuli responsive nanocarriers for disease therapeutics.

Various recent advances and biomedical applications assembled in this book will guide scientists on how to design and develop novel controlled drug release systems.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

1. An overview of stimuli-responsive nanocarriers: State of the art 2. Stimuli responsive strategies: Role of various molecules/moieties facilitating design of stimuli-responsive nanocarriers 3. Vesicular nanocarriers based stimuli-responsive drug delivery systems 4. Stimuli-responsive polymeric nanoparticles as controlled drug delivery system 5. Dendrimers and dendritic nanoparticles for Stimuli-responsive nanomedicine 6. Iron oxide nanocarrier as promising controlled drug delivery vehicle 7. Stimuli-responsive drug delivery systems for immunotherapy 8. Quantum dots based vehicles for controlled drug release in conjunction with bio-imaging 9. Mesoporous silica nanoparticles based stimuli triggered drug release systems 10. Solid lipid nanoparticles based vehicles for stimuli inspired delivery of bioactives 11. Tailored gold nanoparticles for improved controlled over drug release 12. Lipid-polymer hybrid nanoparticles as smart drug delivery platform 13. Polymerosomes as promising vehicle for controlled drug delivery 14. Carbon nanomaterial-based stimuli-responsive drug delivery strategies 15. Protein nanocapsules as a smart drug delivery platform 16. Copper nanoparticles based stimuli-responsive approaches 17. Stimuli-responsive nanogels as promising carriers for controlled delivery of anticancer therapeutics

Authors

Virendra Gajbhiye Scientist in Nanomedicine, Agharkar Research Institute, Pune, India. Dr. Virendra Gajbhiye has been working in the field of nanomedicine for the last 15 years. He has a doctoral degree (Ph.D.) in Pharmaceutical Science with post-doctoral research experience at University of Wisconsin-Madison and Oregon Health and Sciences University. Since 2013 he is working as a Scientist in Nanomedicine at Agharkar Research Institute, Pune, India. He has worked extensively with polymeric nanoparticles specially dendrimers and mesoporous silica nanoparticles. His research interest lies in Nanomedicine, Targeted drug and siRNA delivery, Biomedical application of dendrimers, Biomaterials unimolecular micelles and imaging, Multifunctional polymeric nanoparticles, Nanoparticles in tissue engineering. Kavita Gajbhiye Assistant Professor, Poona College of Pharmacy, Bharati Vidyapeeth Deemed University, Pune, India. Dr. Kavita Gajbhiye has been working in the field of nanomedicine for the last 15 years. She completed her M. Pharm and Ph.D. at Dr. H. S. Gour University, Sagar, MP, India. She has worked as SERB National Post-doctoral Fellow at CSIR-National Chemical Laboratory, Pune, India for two years. The major focus of her research is the synthesis and evaluation of dibolock and triblock polymer based nanoconstructs intended for drug delivery and other biomedical applications. She is presently working as Assistant Professor at Poona College of Pharmacy, Bharati Vidyapeeth Deemed University, Pune, India. Furthermore, as a principal investigator, she has received research grant from SERB, Govt. of India. Seungpyo Hong Professor of Pharmaceutics, Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin-Madison, USA. Prof. Seungpyo Hong is Professor of Pharmaceutics in the Pharmaceutical Sciences Division, School of Pharmacy at the University of Wisconsin-Madison (USA). He serves as Associate Editor for Nanomedicine: Nanotechnology, Biology and Medicine (Elsevier). He graduated from Hanyang University, Seoul, Korea with BS and MS degrees in polymer engineering. He started his PhD study in Macromolecular Science and Engineering at the University of Michigan. After, he joined Massachusetts Institute of Technology (MIT) as a postdoctoral associate in the laboratory of Prof. Robert Langer. From 2008 to 2014, Seungpyo was Assistant Professor in the College of Pharmacy at the University of Illinois at Chicago (UIC) where he was promoted to Associate Professor with tenure in 2014, and subsequently joined the UW-Madison faculty as full Professor in 2016. Since 2008, he has led a research group under the major research theme of "Biomimetic Nanotechnology� for cancer diagnosis and treatment.